SIMULANDS logo — Redefine Training and R&D in Structural Interventions. 
Huma...

SIMULANDS

Redefine Training and R&D in Structural Interventions. Human Grade Simulators: Real Devices/Real Images/Real Heart Team

Founded 2019 Switzerland Switzerland 20 employees Seed Total: $10.00M Health Care, Medical Devices

General Information

Company Name SIMULANDS
Founded Year 2019
Location Switzerland Switzerland +1
Employees 20
Industries Health Care, Medical Devices
Funding Stage Seed
Social

Get notified when SIMULANDS moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About SIMULANDS

Simulands is a Switzerland-based startup focusing on redefining the training and R&D in Structural Interventions. Founded in 2019, the company has received a €10.00M Seed Round investment on 02 March 2023 from SHS Capital. Simulands aims to revolutionize R&D and Education in the Structural Heart space by developing Human Grade simulators as an alternative to traditional animal research practices. By adhering to the 3R principles (replacement, reduction, and refinement), Simulands' simulators are more practical, cost-effective, and ethical. The company's simulators are designed and validated according to all relevant ISO normative requirements, meeting benchmarks of various competent authorities, ethics committees, and notified bodies (CE, FDA, MDR). Additionally, Simulands offers joint training programs catering to a wide range of experience and knowledge levels. With a strong focus on replicating real procedure experiences and providing actual procedural imaging guidance, Simulands aims to evolve the role of simulators from demo tools to comprehensive educational, certification, and recertification platforms. Overall, Simulands is positioned at the forefront of innovation within the Health Care industry, addressing crucial needs for advancement in medical training and R&D.

Taxonomy: medical simulation, R&D, structural heart, cardiovascular training, human grade simulators, ISO standards, ethics in research, certification programs, technology in healthcare, patient outcomes, educational platforms, clinical equivalence, FDA compliance, training programs

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round €10.00M 1 02 Mar 2023

SIMULANDS Alternatives & Competitors

SIMULANDS vs

Makes professional XR training simulators for public and private services.

1 employees
SIMULANDS vs
VSTEP Simulation
VSTEP Simulation The Netherlands

Leading in Simulation & Virtual Solutions

65 employees
SIMULANDS vs
FAAC Incorporated
FAAC Incorporated United States

High-Fidelity Simulation Solutions

186 employees
Government and Military, Manufacturing

FAQ About SIMULANDS

Redefine Training and R&D in Structural Interventions. Human Grade Simulators: Real Devices/Real Images/Real Heart Team
SIMULANDS was founded in 2019.
SIMULANDS is headquartered in Switzerland.
SIMULANDS operates in the following industries: Health Care, Medical Devices.
SIMULANDS has approximately 20 employees.
SIMULANDS has completed 1 funding round, raising a total of $10.00M. The latest funding stage is Seed.
Top alternatives and competitors to SIMULANDS include Simprosoft, VSTEP Simulation, FAAC Incorporated, Oryx Simulations, Heart Foundation NZ. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
SIMULANDS and Simprosoft are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors SIMULANDS and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy